Pancreatic Cancer Research

ResearcherUniversity of PaduaNo recent work listed

Lucia Moletta

ORCID-verified (high confidence, 0.95), identity_conf@1As of 8 November 2026

Matched on ORCID iD 0000-0003-4041-5721; OpenAlex author ID A5019079341. Sources: OpenAlex.

Their work

Papers
10 (first author 3, last author 3)
Trials
0
Grants
0
Labs led
1
Collaborators
11
Papers, trials and grants by year

2015: 1 paper · 2016: none · 2017: 1 paper · 2018: none · 2019: 1 paper · 2020: 2 papers · 2021: 4 papers · 2022: none · 2023: 1 paper

Papers 10

  1. Paraneoplastic myopathy-related rhabdomyolysis and pancreatic cancer: A case report and review of the literature. First author DOI 10.12998/wjcc.v11.i28.6823↗
  2. The role of FDG PET/CT or PET/MRI in assessing response to neoadjuvant therapy for patients with borderline or resectable pancreatic cancer: a systematic liter… Co-author DOI 10.1007/s12149-021-01629-0↗
  3. Systematic Review and Meta-Analysis of Surgical Treatment for Isolated Local Recurrence of Pancreatic Cancer. Last author DOI 10.3390/cancers13061277↗
  4. Does Pancreatic Fistula Affect Long-Term Survival after Resection for Pancreatic Cancer? A Systematic Review and Meta-Analysis. Co-author DOI 10.3390/cancers13225803↗
  5. The Prognostic Value of Low Muscle Mass in Pancreatic Cancer Patients: A Systematic Review and Meta-Analysis. First author DOI 10.3390/jcm10143033↗
  6. Genome-wide association study identifies an early onset pancreatic cancer risk locus. Co-author DOI 10.1002/ijc.33004↗
  7. Prognostic Implications of 18-FDG Positron Emission Tomography/Computed Tomography in Resectable Pancreatic Cancer. Last author DOI 10.3390/jcm9072169↗
  8. Surgery for Recurrent Pancreatic Cancer: Is It Effective? Co-author DOI 10.3390/cancers11070991↗
  9. Para-aortic node involvement is not an independent predictor of survival after resection for pancreatic cancer. Last author DOI 10.3748/wjg.v23.i24.4399↗
  10. Multimodality treatment of recurrent pancreatic cancer: Mith or reality? First author DOI 10.4251/wjgo.v7.i12.375↗

Closest collaborators

The 11 strongest of 11 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.

  1. Cosimo Sperti · 9 shared papers, 2015–2023 · strength 1.16
  2. Simone Serafini · 7 shared papers, 2019–2023 · strength 1.01
  3. Elisa Sefora Pierobon · 3 shared papers, 2019–2023 · strength 0.46
  4. Andrea Grego · 2 shared papers, 2020–2021 · strength 0.27
  5. Andrea Costantini · 1 shared paper, 2023 · strength 0.22
  6. Stefano Merigliano · 2 shared papers, 2015–2021 · strength 0.21
  7. Diego Cecchin · 1 shared paper, 2021 · strength 0.13
  8. Laura Evangelista · 1 shared paper, 2021 · strength 0.13
  9. Francesca Bergamo · 1 shared paper, 2021 · strength 0.13
  10. Valentina Beltrame · 1 shared paper, 2017 · strength 0.07
  11. Mario Gruppo · 1 shared paper, 2017 · strength 0.07

How to reach this person

A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.